<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04045262</url>
  </required_header>
  <id_info>
    <org_study_id>EELVC02</org_study_id>
    <nct_id>NCT04045262</nct_id>
  </id_info>
  <brief_title>Clinical Validation of Continuous and Non-invasive Monitoring of Effective Pulmonary Volume.</brief_title>
  <official_title>Clinical Validation of Continuous and Non-invasive Monitoring of Effective Pulmonary Volume Based on Exhaled CO2 Kinetics in Ventilated Patients.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fernando Suarez Sipmann</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fundación de Investigación Biomédica - Hospital Universitario de La Princesa</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to evaluate/validate a new non-invasive method to continuously&#xD;
      monitor effective lung volume in critically ill patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The capnodinamyc method is a new monitoring method that provides continuous (breath by&#xD;
      breath) measurements of effective pulmonary blood flow (EPBF) and effective end-expiratory l&#xD;
      lung volume (EELVCO2). The former refers to the non-shunted fraction of cardiac output and&#xD;
      the latter to the functional end-expiratory lung volume (EELV) that contains CO2.&#xD;
&#xD;
      The capnodynamic method is based on the advanced analysis of CO2 kinetics and the law of&#xD;
      Conservation of mass. It states that lungs have to eliminate a similar amounts of CO2 as&#xD;
      produced by aerobic metabolism and reaches the lung via pulmonary perfusion. For its&#xD;
      calculation, two different measurements are needed:&#xD;
&#xD;
        1. Exhaled CO2 measured by infrared optic sensor technology placed in a mainstream&#xD;
           configuration between the endotracheal tube and the &quot;Y&quot; piece of the ventilator&#xD;
           respiratory circuit.&#xD;
&#xD;
        2. Flow, airway pressure and ventilatory volumes measured by the mechanical ventilator&#xD;
           spirometer.&#xD;
&#xD;
      The method requires the generation of cyclic small changes in the alveolar concentration of&#xD;
      CO2 which is achieved by introducing a slightly modified breathing pattern. It consists of&#xD;
      adding a short expiratory hold in each 3 out of 9 consecutive breaths and requires the&#xD;
      patient to be in passive breathing conditions under mechanical ventilation.&#xD;
&#xD;
      EPBF and EELVCO2 have been validated in experimental conditions and the first validations in&#xD;
      patients in the setting of general anesthesia are under way.&#xD;
&#xD;
      Methods:&#xD;
&#xD;
      This study on EELVCO2 in critically ill patients involves 2 types of evaluations:&#xD;
&#xD;
      The validation of absolute values of EELV by comparing it with CTsan. The trending ability of&#xD;
      EELVCO2 in critically ill patients by comparing it with EIT.&#xD;
&#xD;
      A calculated sample size of 30 patients is required for each objective.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 4, 2019</start_date>
  <completion_date type="Anticipated">November 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Validation of the measurement of absolute values of effective lung volume</measure>
    <time_frame>1 day</time_frame>
    <description>To validate the measurement of absolute values of effective lung volume by the capnodynamic method previously described, as an estimate of end-expiratory lung volume. For this purpose the capnodynamic method will be compared with gold standard reference method for measuring lung volumes, the computerized tomography scan (CTscan).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Analyze to which pulmonary compartments does effective lung volume most closely correlate</measure>
    <time_frame>1 day</time_frame>
    <description>Tomographic aeration level according to the density distribution analysis (non aerated, poorly aerated, normally and hyper aerated) does effective lung volume most closely correlate; taking into account that the CTscan measures an anatomic rather than a functional lung volume.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Improvement of capnodynamic ELV measurement</measure>
    <time_frame>1 day</time_frame>
    <description>To determine the effects of lung collapse on the accuracy and precision of the capnodynamic ELV measurement.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Trending ability of the capnodynamic end-expiratory lung volume method</measure>
    <time_frame>1 day</time_frame>
    <description>Breath by breath changes in EELVCO2 will be compared with breath by breath changes in lung aeration measured by electrical impedance tomography.</description>
  </primary_outcome>
  <enrollment type="Anticipated">32</enrollment>
  <condition>Critical Illness</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Critically ill patients undergoing mechanical ventilation&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All patients on mechanical ventilation in passive breathing conditions in which a&#xD;
             thoracic CTscan has been indicated for medical reasons and those with an EIT and a&#xD;
             continuous cardiac monitoring&#xD;
&#xD;
          -  Informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Hemodynamic instability&#xD;
&#xD;
          -  Presence of barotrauma/ pneumothorax&#xD;
&#xD;
          -  Presence of bronchopleural fistulas&#xD;
&#xD;
          -  Thorax alterations that preclude the positioning of the EIT electrode belt (usually at&#xD;
             the IV intercostal space).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fernando Suarez Sipmann, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fundación de Investigación Biomédica - Hospital Universitario de La Princesa</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Fernando Suarez Sipmann, MD PhD</last_name>
    <phone>+34 915202200</phone>
    <email>fsuarezsipmann@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Juan Antonio Sanchez Giralt, MD PhD</last_name>
    <phone>+34 915202200</phone>
    <email>jasanchezgiralt@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital Universitario de la Princesa</name>
      <address>
        <city>Madrid</city>
        <zip>28006</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>August 2, 2019</study_first_submitted>
  <study_first_submitted_qc>August 2, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 5, 2019</study_first_posted>
  <last_update_submitted>August 13, 2020</last_update_submitted>
  <last_update_submitted_qc>August 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Fundación de Investigación Biomédica - Hospital Universitario de La Princesa</investigator_affiliation>
    <investigator_full_name>Fernando Suarez Sipmann</investigator_full_name>
    <investigator_title>MD PhD Intesive Care Medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Critical Illness</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

